The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Testosterone Undecanoate Market Research Report 2024
Synopsis
Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
The global Testosterone Undecanoate market was valued at US$ 564 million in 2023 and is anticipated to reach US$ 827.4 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Testosterone Undecanoate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Testosterone Undecanoate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Testosterone Undecanoate include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Testosterone Undecanoate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Undecanoate.
Report Scope
The Testosterone Undecanoate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Undecanoate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Undecanoate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Segment by Type
Injection
Oral
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Undecanoate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Undecanoate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
The global Testosterone Undecanoate market was valued at US$ 564 million in 2023 and is anticipated to reach US$ 827.4 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Testosterone Undecanoate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Testosterone Undecanoate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Testosterone Undecanoate include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Testosterone Undecanoate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Undecanoate.
Report Scope
The Testosterone Undecanoate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Undecanoate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Undecanoate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Segment by Type
Injection
Oral
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Undecanoate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Undecanoate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Testosterone Undecanoate Market Overview
1.1 Product Overview and Scope of Testosterone Undecanoate
1.2 Testosterone Undecanoate Segment by Type
1.2.1 Global Testosterone Undecanoate Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Oral
1.3 Testosterone Undecanoate Segment by Application
1.3.1 Global Testosterone Undecanoate Market Value by Application: (2024-2030)
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Global Testosterone Undecanoate Market Size Estimates and Forecasts
1.4.1 Global Testosterone Undecanoate Revenue 2019-2030
1.4.2 Global Testosterone Undecanoate Sales 2019-2030
1.4.3 Global Testosterone Undecanoate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Testosterone Undecanoate Market Competition by Manufacturers
2.1 Global Testosterone Undecanoate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Testosterone Undecanoate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Testosterone Undecanoate Average Price by Manufacturers (2019-2024)
2.4 Global Testosterone Undecanoate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Testosterone Undecanoate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Undecanoate, Product Type & Application
2.7 Testosterone Undecanoate Market Competitive Situation and Trends
2.7.1 Testosterone Undecanoate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Testosterone Undecanoate Players Market Share by Revenue
2.7.3 Global Testosterone Undecanoate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Testosterone Undecanoate Retrospective Market Scenario by Region
3.1 Global Testosterone Undecanoate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Testosterone Undecanoate Global Testosterone Undecanoate Sales by Region: 2019-2030
3.2.1 Global Testosterone Undecanoate Sales by Region: 2019-2024
3.2.2 Global Testosterone Undecanoate Sales by Region: 2025-2030
3.3 Global Testosterone Undecanoate Global Testosterone Undecanoate Revenue by Region: 2019-2030
3.3.1 Global Testosterone Undecanoate Revenue by Region: 2019-2024
3.3.2 Global Testosterone Undecanoate Revenue by Region: 2025-2030
3.4 North America Testosterone Undecanoate Market Facts & Figures by Country
3.4.1 North America Testosterone Undecanoate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Testosterone Undecanoate Sales by Country (2019-2030)
3.4.3 North America Testosterone Undecanoate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Testosterone Undecanoate Market Facts & Figures by Country
3.5.1 Europe Testosterone Undecanoate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Testosterone Undecanoate Sales by Country (2019-2030)
3.5.3 Europe Testosterone Undecanoate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Undecanoate Market Facts & Figures by Country
3.6.1 Asia Pacific Testosterone Undecanoate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Testosterone Undecanoate Sales by Country (2019-2030)
3.6.3 Asia Pacific Testosterone Undecanoate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Testosterone Undecanoate Market Facts & Figures by Country
3.7.1 Latin America Testosterone Undecanoate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Testosterone Undecanoate Sales by Country (2019-2030)
3.7.3 Latin America Testosterone Undecanoate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Testosterone Undecanoate Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Undecanoate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Testosterone Undecanoate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Testosterone Undecanoate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Undecanoate Sales by Type (2019-2030)
4.1.1 Global Testosterone Undecanoate Sales by Type (2019-2024)
4.1.2 Global Testosterone Undecanoate Sales by Type (2025-2030)
4.1.3 Global Testosterone Undecanoate Sales Market Share by Type (2019-2030)
4.2 Global Testosterone Undecanoate Revenue by Type (2019-2030)
4.2.1 Global Testosterone Undecanoate Revenue by Type (2019-2024)
4.2.2 Global Testosterone Undecanoate Revenue by Type (2025-2030)
4.2.3 Global Testosterone Undecanoate Revenue Market Share by Type (2019-2030)
4.3 Global Testosterone Undecanoate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Testosterone Undecanoate Sales by Application (2019-2030)
5.1.1 Global Testosterone Undecanoate Sales by Application (2019-2024)
5.1.2 Global Testosterone Undecanoate Sales by Application (2025-2030)
5.1.3 Global Testosterone Undecanoate Sales Market Share by Application (2019-2030)
5.2 Global Testosterone Undecanoate Revenue by Application (2019-2030)
5.2.1 Global Testosterone Undecanoate Revenue by Application (2019-2024)
5.2.2 Global Testosterone Undecanoate Revenue by Application (2025-2030)
5.2.3 Global Testosterone Undecanoate Revenue Market Share by Application (2019-2030)
5.3 Global Testosterone Undecanoate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Testosterone Undecanoate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer AG Testosterone Undecanoate Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Endo Pharmaceuticals
6.2.1 Endo Pharmaceuticals Corporation Information
6.2.2 Endo Pharmaceuticals Description and Business Overview
6.2.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Endo Pharmaceuticals Testosterone Undecanoate Product Portfolio
6.2.5 Endo Pharmaceuticals Recent Developments/Updates
6.3 Merck Sharp & Dohme
6.3.1 Merck Sharp & Dohme Corporation Information
6.3.2 Merck Sharp & Dohme Description and Business Overview
6.3.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Sharp & Dohme Testosterone Undecanoate Product Portfolio
6.3.5 Merck Sharp & Dohme Recent Developments/Updates
6.4 Taro Pharmaceutical
6.4.1 Taro Pharmaceutical Corporation Information
6.4.2 Taro Pharmaceutical Description and Business Overview
6.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Taro Pharmaceutical Testosterone Undecanoate Product Portfolio
6.4.5 Taro Pharmaceutical Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Testosterone Undecanoate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Testosterone Undecanoate Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Zhejiang Xianju Pharmaceutical
6.6.1 Zhejiang Xianju Pharmaceutical Corporation Information
6.6.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.6.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Portfolio
6.6.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.7 Zhejiang Medicine Co.
6.6.1 Zhejiang Medicine Co. Corporation Information
6.6.2 Zhejiang Medicine Co. Description and Business Overview
6.6.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhejiang Medicine Co. Testosterone Undecanoate Product Portfolio
6.7.5 Zhejiang Medicine Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Undecanoate Industry Chain Analysis
7.2 Testosterone Undecanoate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Undecanoate Production Mode & Process
7.4 Testosterone Undecanoate Sales and Marketing
7.4.1 Testosterone Undecanoate Sales Channels
7.4.2 Testosterone Undecanoate Distributors
7.5 Testosterone Undecanoate Customers
8 Testosterone Undecanoate Market Dynamics
8.1 Testosterone Undecanoate Industry Trends
8.2 Testosterone Undecanoate Market Drivers
8.3 Testosterone Undecanoate Market Challenges
8.4 Testosterone Undecanoate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
